Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05984186 · ClinicalTrials.gov registry record · NA
Effect of High Velocity/Hyperoxic Breathing Therapy on Blood Lactate Decline
A NA study, sponsored by Vapotherm.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT05984186: Completed NA study, sponsored by Vapotherm.
NCT05984186 is a NA study that has completed, run by Vapotherm. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05984186, a NA study, has completed, sponsored by Vapotherm.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The study will evaluate the impact of high velocity therapy (HVT) on reduction of work of breathing (as implied by breath frequency) and enhanced blood lactate decline during recovery from a Wingate-type Exercise test. The study will include four study segments, corresponding to four different therapy settings.
Primary Outcome
The change in blood lactate starting from the exercise test throughout the recovery period
Interventions
- DEVICE High Velocity Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2023-03-06 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
What the finished NCT05984186 record still lists
NCT05984186 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which High Velocity Therapy is the first listed.
NCT05984186 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05984186 about?
NCT05984186 is a clinical study titled "Effect of High Velocity/Hyperoxic Breathing Therapy on Blood Lactate Decline". The study will evaluate the impact of high velocity therapy (HVT) on reduction of work of breathing (as implied by breath frequency) and enhanced blood lactate decline during recovery from a Wingate-type Exercise test. The study will include four study segments, corresponding to four different thera...
What is the current status of trial NCT05984186?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2023-03-06. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT05984186?
The interventions under investigation include: High Velocity Therapy (DEVICE).
Who is sponsoring clinical trial NCT05984186?
This trial is sponsored by Vapotherm, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05984186's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI